Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.6800-0.0400 (-1.08%)
At close: 04:00PM EDT
3.6800 0.00 (0.00%)
After hours: 04:01PM EDT
Advertisement

Harvard Bioscience, Inc.

84 October Hill Road
Suite 10
Holliston, MA 01746
United States
508 893 8999
https://www.harvardbioscience.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees475

Key Executives

NameTitlePayExercisedYear Born
Mr. James W. GreenPres, CEO & Chairman1.02MN/A1958
Mr. Michael A. RossiChief Financial Officer478.75kN/A1974
Mr. Kenneth Fletcher OlsonExec. Officer414.31kN/A1962
Mr. Jacques Coumans Ph.D.Chief Marketing OfficerN/AN/AN/A
David SiroisDirector of Corp. Accounting & SEC ReportingN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

Corporate Governance

Harvard Bioscience, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 5. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 7; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement